Skip to main content

Caligan Partners LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1727492 NEW YORK, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$160,735,578
+$58,472,943 QoQ
Shares Held
1,652,808
+28.7% QoQ
Ownership
0.777%
of shares outstanding
% of Portfolio
11.37%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026
CallValue
$22,260,525
CallShares
228,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Caligan Partners LP holds $1,086,520,401 across 21 Biotechnology names. RVMD ranks #2 (14.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 RVMD
Revolution Medicines, Inc.
This page
1,652,808 $160,735,578

All Filings in RVMD

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,260,525 228,900
2026-03-31 $160,735,578 1,652,808
2025-12-31 $102,262,635 1,283,900
2025-09-30 $49,700,428 1,064,249
2025-06-30 $23,429,159 636,835
2025-03-31 $16,442,400 465,000